Investor Presentation First Nine Months of 2022 slide image

Investor Presentation First Nine Months of 2022

160 Investor presentation First nine months of 2022 Barriers to access go beyond price Diabetes Compass launched with World Diabetes Foundation Many healthcare systems in LMICs are overburdened Aims to reduce vulnerabilities through innovative digital solutions to support health workers and people with diabetes Pilots in Sri Lanka and Tanzania have been launched Roll-out of digital products expected to begin in Q1 2023 Thermal solution for human insulin can address one key access to care barrier Strict insulin storage recommendations are hard to meet in humanitarian settings and where access to refrigeration is low ⚫ The positive scientific opinion received from EMA in April supports obtaining the national approvals for additional option for storage outside of refrigeration prior to first use National submission ongoing in >50 countries, e.g. submitted in India and Bangladesh in July 2022 iCare initiative towards strengthening health infrastructure in Middle Africa ⚫ A business-integrated model improving access to treatment and care . • . Capacity: 6,300 HCPs trained Affordability: 32,300 underserved patients reached with insulin Reach: Onboarded new distributors to reduce mark-ups Empowerment: 10,900 patients enrolled in patient empowerment programmes DIABETES COMPASS Actrapid CARE ...to Defeat Diabetes Note: The Diabetes Compass was launched by the World Diabetes Foundation with more information on Diabetes Compass | World diabetes foundation. Diabetes Compass is funded by a 100 million DKK joint donation from Novo Nordisk A/S and the Novo Nordisk Foundation. HCP: Health care professional; LMIC: Low- and middle-incomes countries Novo NordiskⓇ
View entire presentation